Britain’s Life Sciences Strategy Draws Mixed Reaction from Pharma Sector
Industry voices both praise and concerns over new government plan
The UK government's newly unveiled life sciences strategy has received a mixed reception from the pharmaceutical industry, with leaders welcoming efforts to boost research and innovation but warning that regulatory and funding gaps could undermine its goals.
